Insulin revenues were affected by a scheduled facility shutdown in August for maintenance, with manufacturing expected to resume in December. Shares of Torrent Pharmaceuticals Ltd ended at ₹3,418.80, up by ₹101.55, or 3.06%, on the BSE.
Insulin revenues were affected by a scheduled facility shutdown in August for maintenance, with manufacturing expected to resume in December. Shares of Torrent Pharmaceuticals Ltd ended at ₹3,418.80, up by ₹101.55, or 3.06%, on the BSE.